MDT icon

Medtronic

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 37.5%
Negative

Positive
Seeking Alpha
14 hours ago
Best Dividend Aristocrats For March 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.22%, below last year's trend and potentially signaling headwinds.
Best Dividend Aristocrats For March 2026
Neutral
PRNewsWire
2 days ago
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor
Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the first and only solution to integrate data from the InPen™ smart insulin pen and the Simplera™ sensor into a single mobile app, is designed to help people who use multiple daily injections (MDI) to better control their diabetes.
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor
Neutral
PRNewsWire
3 days ago
MiniMed announces launch of IPO roadshow
GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of its common stock. The proposed offering is part of Medtronic's previously announced plan to separate its Diabetes business into an independent public company.
MiniMed announces launch of IPO roadshow
Positive
Reuters
3 days ago
Medtronic's MiniMed aims to raise $784 million in US IPO
Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.
Medtronic's MiniMed aims to raise $784 million in US IPO
Positive
The Motley Fool
5 days ago
1 Reason I'd Buy Medtronic Stock and Never Sell
Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business.
1 Reason I'd Buy Medtronic Stock and Never Sell
Neutral
The Motley Fool
5 days ago
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash
It isn't easy to find a healthcare company that regularly pays a generous dividend. It's even harder to find one with an annual raise streak approaching 50 years.
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash
Positive
The Motley Fool
6 days ago
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
Medtronic is a large and diversified medical device company with a history of innovation. It has also consistently raised its dividend and is closing in now on Dividend King status.
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
Neutral
Benzinga
9 days ago
Medtronic Analysts Cut Their Forecasts After Q3 Earnings
Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday.
Medtronic Analysts Cut Their Forecasts After Q3 Earnings
Positive
MarketBeat
10 days ago
Medtronic's “Textbook” Reversal: How High Can It Really Go in 2026?
Medtronic's NYSE: MDT stock price is amid a textbook reversal, having formed a Head & Shoulders Pattern and broken to fresh highs, confirming the baseline as a critical pivot point. The question now is how high the stock might rise.
Medtronic's “Textbook” Reversal: How High Can It Really Go in 2026?
Positive
Benzinga
10 days ago
Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth
Adjusted earnings of $1.36 per share also beat expectations of $1.33.
Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth